查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000671

非PVC輸液袋市場：按產品類型、材料、容量、應用和最終用戶分類－2026-2032年全球市場預測

Non-PVC IV bags Market by Product Type, Material, Capacity, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年非PVC輸液袋市值為27.4億美元，預計2026年將達31億美元。以13.11%的複合年成長率計算，預計到2032年將達到64.9億美元。

主要市場統計數據
基準年 2025 27.4億美元
預計年份：2026年 31億美元
預測年份 2032 64.9億美元
複合年成長率 (%) 13.11%

對非PVC輸液袋進行全面分析，重點在於影響採購和臨床應用的材料創新、監管因素和永續性因素。

非PVC輸液袋的出現，融合了材料科學創新、臨床安全考量和永續性要求。聚合物技術的進步，例如新型彈性體和聚烯，使得開發出柔軟性醫用級輸液袋成為可能，避免了傳統PVC結構中與塑化劑相關的風險。這項發展反映了臨床醫生偏好和醫療機構採購政策的轉變，即傾向於選擇能夠降低滲漏風險和患者長期暴露風險的醫療設備。

一項變革性的改變，將重塑非PVC輸液袋的生態系統。

非PVC輸液袋市場正經歷技術和結構趨勢的融合重塑，這些趨勢正在改變競爭格局和價值鏈。材料科學的突破拓寬了滿足無菌性、柔軟性和貼合性要求的實用聚合物的範圍，使製造商能夠重新設計外形規格，並整合符合現代臨床通訊協定的藥物相容性。同時，醫療保健系統日益成長的環保期望也加速了對全生命週期環境影響更低產品的需求。

近期美國關稅措施對非PVC靜脈輸液供應鏈及採購選擇的累積影響。

影響醫療設備原料和包裝的關稅政策調整，為非聚氯乙烯（PVC）輸液袋製造商及其下游醫療客戶的採購決策帶來了新的變數。某些聚合物進口和組件關稅的提高可能會增加部分原料的到貨成本，迫使製造商重新評估其供應商分佈和材料替代策略。這加速了尋找能夠提供穩定品質並降低關稅風險的替代上游供應商以及實現本地化生產的進程。

從材料、類型、應用、最終用戶和生產能力等方面深入了解非PVC輸液袋的關鍵細分市場。

材料的選擇對臨床適用性和生產過程有顯著影響。特別是乙烯-醋酸乙烯酯共聚物（EVA）、聚乙烯和聚丙烯各自具有不同的機械和化學性能，這些性能會影響材料的滲出性、耐滅菌性和可回收性。當柔軟性和透明度至關重要時，EVA通常是首選材料；而聚乙烯和聚丙烯則在剛性、耐化學性和熱成型性能方面各有側重，這會影響密封和填充線的完整性。了解這些材料的優缺點對於使產品設計與最終用戶的操作和臨床工作流程相匹配至關重要。

美洲、歐洲、中東和非洲以及亞太地區非PVC靜脈注射容器的趨勢和戰略考量。

在美洲，醫療機構的臨床安全標準和永續發展計畫鼓勵使用非PVC替代品，這共同推動要素了市場需求。儘管區域製造能力和完善的分銷網路能夠實現快速的產品供應，但採購部門仍然對成本高度敏感，並專注於供應商的業務永續營運。因此，能夠提供透明供應鏈和生命週期影響數據的製造商往往在該地區更受歡迎。

非PVC輸液袋市場中影響製造商策略和合作夥伴生態系統的競爭和企業趨勢。

非PVC輸液袋市場的競爭格局由產品創新、供應鏈可靠性及臨床及環境性能驗證能力三者共同決定。領先的製造商正投資於端到端的檢驗項目，以記錄萃取物、洗脫液和生物相容性，同時透過自動化和品質源自於設計 (QbD)調查方法提高生產效率。這些投資正在加快新配方產品的上市速度，並增強醫院採購委員會的信心。

為尋求加速採用非PVC輸液袋並建立強大的產品線的行業領導者提供切實可行的策略建議。

在產品開發的早期階段，應優先進行材料表徵以及嚴格的萃取和洗脫測試，以縮短監管核准流程並建立臨床可靠性。儘早投資於全面的生物相容性和穩定性測試，將有助於您向臨床醫生和採購團隊傳遞更清晰的安全訊息。同時，應使設計選擇與常見的臨床工作流程保持一致，以最大限度地減少與輸液幫浦、輸液管路和床邊操作整合時的摩擦。

所採用的調查方法旨在深入了解非PVC靜脈輸液容器的現狀，並得出切實可行的見解。

本分析整合了來自專家訪談、技術白皮書、監管指導文件以及採購和臨床相關人員的實踐經驗，以確保研究結果立足於實際決策情境。訪談對象涵蓋材料科學家、生產負責人、藥局主任和採購負責人，旨在收集他們對材料性能、供應鏈限制因素以及臨床應用障礙的不同觀點。

關於相關人員向非聚氯乙烯（PVC）靜脈輸液過渡過程中面臨的策略挑戰的結論

轉向使用非PVC輸液袋反映了更廣泛的醫療保健趨勢，即優先考慮患者安全、環境責任和供應鏈韌性。材料創新、監管部門對萃取物和洗脫液的重視，以及納入永續性標準的醫療保健採購框架，共同創造了一種環境：除了技術性能之外，還要求產品具備可證明的安全性和生命週期記錄。那些能夠使其產品設計、測試和供應策略與這些基本要求一致的企業，將更有能力贏得醫療機構的信任。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 非PVC輸液袋市場：依產品類型分類

  • 多重腔
    • 三腔型
    • 雙腔型
  • 單人房

第9章 非PVC輸液袋市場：依材料分類

  • 乙烯-醋酸乙烯酯
  • 聚乙烯
  • 聚丙烯

第10章 非PVC輸液袋市場：依容量分類

  • 500～1000ml
  • 超過1000毫升
  • 少於500毫升

第11章 非PVC輸液袋市場：依應用領域分類

  • 血液樣本
  • 透析
  • 點滴療法
  • 營養療法

第12章 非PVC輸液袋市場：依最終用戶分類

  • 門診部
  • 診所
  • 居家照護
  • 醫院

第13章 非PVC輸液袋市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 非PVC輸液袋市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 非PVC輸液袋市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國非PVC輸液袋市場

第17章：中國非PVC輸液袋市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. BRAUN MELSUNGEN AG
  • BAXTER INTERNATIONAL INC.
  • China Resources Double-Crane Pharmaceutical Co., Ltd.
  • CHONGQING KANGJIE MEDICAL INSTRUMENTS CO., LTD.
  • Cisen Pharmaceutical Co., Ltd.
  • FRESENIUS KABI AG
  • Huaren Pharmaceutical Co., Ltd.
  • ICU MEDICAL, INC.
  • Jiangxi Sanxin Medtec Co., Ltd.
  • JW Life Science Corporation
  • NIPRO CORPORATION
  • Otsuka Pharmaceutical Co., Ltd.
  • Pharmaceutical Solutions Industry Limited
  • POLY MEDICURE LIMITED
  • PolyCine GmbH
  • PROTEK MEDICAL（SHANGHAI）CO., LTD.
  • RENOLIT SE
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Shanghai XinGen Eco-Technologies Co., Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Sippex
  • SSY Group Limited
  • Technoflex SAS
  • TERUMO CORPORATION
  • Wellpharma Medical Solutions LLC
  • WUJIANG DONGLI MEDICAL PRODUCTS CO., LTD.
Product Code: MRR-8C74ADFC13EF

The Non-PVC IV bags Market was valued at USD 2.74 billion in 2025 and is projected to grow to USD 3.10 billion in 2026, with a CAGR of 13.11%, reaching USD 6.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.74 billion
Estimated Year [2026] USD 3.10 billion
Forecast Year [2032] USD 6.49 billion
CAGR (%) 13.11%

A comprehensive framing of non-PVC intravenous bags highlighting material innovation, regulatory drivers, and sustainability forces shaping procurement and clinical adoption

Non-PVC intravenous containers are at the intersection of material science innovation, clinical safety priorities, and sustainability imperatives. Advances in polymers such as alternative elastomers and polyolefins have enabled the development of flexible, medical-grade bags that avoid the plasticizer-related risks associated with traditional PVC constructions. This evolution reflects both clinician preference and institutional procurement shifts toward devices that mitigate leachables and potential long-term patient exposure concerns.

Beyond clinical safety, environmental and circularity considerations are elevating non-PVC options in formulary deliberations and procurement frameworks. Hospitals and health systems increasingly demand end-to-end traceability and environmentally preferable product attributes, including reduced reliance on phthalates and improved recyclability. Consequently, manufacturers are responding with materials and manufacturing adjustments that prioritize closed-loop processes, ease of sterilization, and compatibility with existing infusion systems.

Regulatory scrutiny and evolving standards for extractables and leachables testing have also pushed non-PVC solutions into the spotlight. Regulatory agencies and standards bodies continue to refine expectations for material characterization, biocompatibility, and labeling. Thus, new entrants and established suppliers must integrate robust testing protocols into product development lifecycles to facilitate timely approvals and hospital adoption.

Taken together, the shift away from PVC for IV bags is not simply a change in raw materials; it represents a systemic reorientation involving supply chain reconfiguration, clinician education, and lifecycle management. These dynamics create opportunities for differentiation through design, safety communication, and sustainability credentials, while also introducing complexity in sourcing, validation, and regulatory pathways.

Transformative Shifts Reshaping the Non-PVC Intravenous Container Ecosystem

The non-PVC IV bag landscape is being reshaped by converging technological and structural trends that are altering competitive dynamics and value chains. Material science breakthroughs have expanded the palette of viable polymers that meet sterility, flexibility, and compatibility requirements, enabling manufacturers to redesign form factors and integrate drug compatibility profiles that align with contemporary clinical protocols. Meanwhile, rising environmental expectations across healthcare systems are accelerating demand signals for products with lower lifecycle environmental footprints.

Concurrently, procurement and supply chain strategies are evolving in response to lessons learned from recent global disruptions. Healthcare providers are diversifying supplier bases, increasing inventory resilience, and placing higher value on suppliers that can demonstrate transparency, validated alternate sourcing, and quick scale-up capabilities. These procurement shifts are complemented by digital transformation in manufacturing and logistics, where automation, quality by design, and traceability tools are becoming differentiators.

Clinical practice is adapting as well, with clinicians and pharmacy teams collaborating earlier in product selection to ensure compatibility with infusion pumps, filters, and bedside workflows. Hospital formulary committees are incorporating sustainability and patient-safety criteria alongside traditional efficacy and cost considerations, which elevates the importance of robust clinical evidence and real-world performance data for non-PVC alternatives.

Finally, regulatory harmonization and standard-setting bodies are increasingly focused on extractables and leachables, biocompatibility, and labeling clarity. These regulatory drivers are forcing manufacturers to invest in more rigorous material characterization and to document lifecycle impacts. Together, these transformative shifts are creating both barriers and avenues for companies that can align material performance, supply chain resilience, and demonstrable clinical value.

Cumulative Impacts of Recent United States Tariff Measures on Non-PVC Intravenous Supply Chains and Procurement Choices

Tariff policy adjustments affecting medical device inputs and packaging have introduced a new variable into the sourcing calculus for non-PVC IV bag manufacturers and their downstream healthcare customers. Increased duties on certain polymer imports and components can raise the landed cost of some raw materials, prompting manufacturers to reevaluate supplier geographies and material substitution strategies. This has led to accelerated efforts to localize production or qualify alternative upstream suppliers that can provide consistent quality while mitigating tariff exposure.

In addition to direct input-cost effects, tariff changes influence inventory management practices. Manufacturers and distributors have adapted by lengthening lead-time buffers, increasing strategic safety stocks, and negotiating multi-year contracts to lock in supply continuity. These responses, while prudent for risk mitigation, can introduce capital and working-capital pressures and may shift supplier relationships toward those with better logistical predictability and tariff-compliant supply chains.

Tariffs also affect procurement behavior at the healthcare provider level. Group purchasing organizations and hospital supply teams are scrutinizing total cost of ownership and supplier resilience more closely, factoring in transport complexity, customs procedures, and potential for sudden cost volatility. Such scrutiny often favors suppliers with transparent sourcing, regional manufacturing presence, or value-added services that reduce procurement friction.

Finally, the tariff-driven landscape fosters accelerated collaborations between manufacturers and polymer producers to develop domestically-sourced grades or tariff-exempt material pathways. These collaborations aim to preserve product performance while alleviating exposure to trade policy fluctuations. Consequently, firms that proactively redesign supply chains or secure tariff-resilient sourcing pathways are better positioned to offer stable pricing and reliable lead times to clinical customers.

Key Segmentation Insights for Non-PVC Intravenous Bags Across Materials, Types, Applications, End Users, and Capacities

Material selection drives clinical compatibility and manufacturing processes, particularly where Ethylene Vinyl Acetate, Polyethylene, and Polypropylene each present distinct mechanical and chemical performance profiles that influence leachables, sterilization tolerance, and recyclability. Ethylene Vinyl Acetate is often favored where flexibility and clarity are prioritized, while Polyethylene and Polypropylene provide different balances of rigidity, chemical resistance, and thermoforming characteristics that affect sealing and fill-line integrity. Understanding these material trade-offs is essential for aligning product design to end-user handling and clinical workflows.

Product architecture matters in clinical delivery scenarios, with non-PVC solutions available as single chamber or multi chamber configurations and multi chamber variants further differentiated into two-chamber and three-chamber formats to support stability and admixture requirements for complex therapies. Single chamber designs are straightforward for routine infusion needs, whereas two-chamber and three-chamber multi chamber formats enable on-demand mixing, reduced compounding at the bedside, and improved stability for multi-component therapies. These distinctions inform procurement decisions in pharmacy compounding environments and influence inventory strategies across care settings.

Application-based segmentation reflects how product attributes are matched to clinical use cases such as blood collection, dialysis, infusion therapy, and nutrition therapy. In blood collection and dialysis, mechanical robustness, anticoagulant compatibility, and certified sterility are primary concerns. Infusion therapy demands precise compatibility with pumps and tubing sets, while nutrition therapy requires bag materials and port designs that support long-dwell administration, particulate control, and compatibility with parenteral nutrition formulations. Each application imposes specific validation and labeling expectations that manufacturers must meet.

End-user contexts shape uptake dynamics, spanning ambulatory centers, clinics, home care, and hospitals. Product selection criteria vary across these settings: ambulatory centers and clinics emphasize ease of use, storage efficiency, and rapid turnover; home care prioritizes portability, patient safety, and simplified administration; hospitals require broad compatibility with diverse clinical devices and strict compliance with infection-control protocols. These divergent priorities necessitate differentiated product portfolios and tailored service models.

Capacity segmentation, covering less than 500 milliliter bags, 500 to 1000 milliliter ranges, and greater than 1000 milliliter capacities, aligns with therapy intensity and workflow design. Smaller volumes are frequently used for bolus or pediatric administration, mid-range capacities support routine infusion and common fluid administration, and larger capacities cater to high-volume needs or specialty applications. Capacity decisions influence packaging, transport efficiency, and storage footprint, which in turn affect procurement and inventory optimization across clinical settings.

Regional Dynamics and Strategic Considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific for Non-PVC Intravenous Containers

In the Americas, demand drivers are shaped by a combination of clinical safety mandates and institutional sustainability programs that incentivize non-PVC alternatives. Regional manufacturing capacity and a well-developed distribution network support rapid product availability, yet procurement organizations remain cost-sensitive and attentive to supplier resilience. Consequently, manufacturers that offer transparent supply chains and lifecycle-impact data often find receptive buyers in this region.

The Europe, Middle East & Africa region is characterized by heterogenous regulatory environments and an elevated focus on environmental and public-health imperatives. European markets in particular emphasize stringent extractables and leachables testing, comprehensive material documentation, and environmental declarations. Medical procurement frameworks also give weight to circular-economy initiatives and extended producer responsibility concepts, which influence adoption timelines and product design choices across the region.

Asia-Pacific presents a varied landscape where rapid healthcare infrastructure development coexists with diverse regulatory regimes and localized supply dynamics. Several countries in the region prioritize domestic manufacturing and are fostering capacity expansion for critical medical consumables. At the same time, cross-border trade and regional supply partnerships play a substantial role in balancing demand surges with production capabilities. Manufacturers that can adapt configurations to local clinical practices and align with regional regulatory requirements tend to achieve stronger market penetration.

Across all regions, convergence is observable in heightened expectations for environmental stewardship, expanded testing for material safety, and supply chain transparency. Manufacturers and distributors that can tailor value propositions to each region's regulatory posture and procurement culture will be better positioned to support adoption and long-term partnerships with healthcare providers.

Competitive and Corporate Trends Shaping Manufacturer Strategies and Partner Ecosystems in the Non-PVC Intravenous Bag Market

Competitive dynamics in the non-PVC IV bag sector are defined by a blend of product innovation, supply chain reliability, and the ability to demonstrate clinical and environmental credentials. Leading manufacturers are investing in end-to-end validation programs that document extractables, leachables, and biocompatibility, while also pursuing manufacturing efficiency gains through automation and quality-by-design methodologies. These investments reduce time-to-market for new formulations and bolster confidence among hospital procurement committees.

Strategic partnerships between polymer suppliers, contract manufacturers, and clinical research organizations are becoming more common as firms seek to accelerate material qualification and regulatory submissions. Contract manufacturing relationships enable scale-up flexibility, while collaborations with polymer innovators can yield proprietary formulations that balance performance with recyclability. Such alliances often create differentiated value propositions that combine material science expertise with clinical validation capabilities.

Service differentiation is increasingly significant, with several companies offering bundled solutions that include device compatibility testing, supply continuity guarantees, and sustainability documentation. These value-added services reduce procurement friction and align manufacturer offerings with the operational realities of health systems. Additionally, manufacturing footprint optimization and nearshoring initiatives are common tactics to reduce lead times and limit exposure to policy-driven trade disruptions.

Mergers, acquisitions, and licensing arrangements are also influencing competitive landscapes, as firms seek to complement product portfolios with technical capabilities or geographic reach. Ultimately, corporate success in this sector depends on the ability to align product performance with regulatory compliance, provide transparent supply assurances, and articulate measurable sustainability benefits to institutional buyers.

Actionable Strategic Recommendations for Industry Leaders Seeking to Accelerate Adoption and Build Resilient Non-PVC Intravenous Bag Offerings

Prioritize material characterization and rigorous extractables and leachables testing early in product development to shorten regulatory pathways and build clinical confidence. Early investment in comprehensive biocompatibility and stability studies enables clearer safety messaging to clinicians and procurement teams. Simultaneously, align design choices with typical clinical workflows to minimize integration friction with infusion pumps, tubing sets, and bedside procedures.

Strengthen supply chain resilience by diversifying supplier geographies, qualifying secondary sources for critical polymer inputs, and exploring regional production hubs to mitigate tariff and logistics volatility. Establish long-term relationships with key polymer suppliers and consider strategic inventory buffers combined with demand-sensing analytics to balance cost and availability. Transparency across the supply chain will be a differentiator for institutional purchasers focused on reliability.

Differentiate through service and sustainability: provide lifecycle assessments, recyclability pathways, and end-of-life management strategies alongside product offerings. Coupling technical performance with verified environmental credentials will enhance appeal to procurement teams that incorporate sustainability into selection criteria. Offer technical support packages that facilitate clinician training, bedside adoption, and pharmacy validation to reduce onboarding friction.

Invest in modular product platforms that allow for rapid configuration of single chamber and multi chamber formats and varied capacities to meet diverse clinical needs. Modular platforms reduce tooling costs and accelerate responsiveness to shifting application demands. Complement product modularity with targeted clinical evidence generation that demonstrates safe, effective use across blood collection, dialysis, infusion therapy, and nutrition therapy scenarios.

Finally, engage proactively with regulatory bodies and standards organizations to stay ahead of evolving expectations on material testing, labeling, and environmental reporting. Regulatory engagement not only reduces approval uncertainty but also positions companies as trusted partners to health systems and procurement consortia.

Research Methodology Employed to Produce Robust, Actionable Insights into the Non-PVC Intravenous Container Landscape

This analysis synthesizes evidence from primary expert interviews, technical whitepapers, regulatory guidance documents, and operational insights from procurement and clinical stakeholders to ensure findings are grounded in real-world decision contexts. Primary interviews were conducted with a cross-section of materials scientists, manufacturing leaders, pharmacy directors, and procurement professionals to capture diverse perspectives on material performance, supply chain constraints, and clinical adoption barriers.

Secondary sources include peer-reviewed literature on polymer performance in medical devices, publicly available regulatory guidance on extractables and leachables, and aggregated clinical practice resources that inform usability and compatibility considerations. Data triangulation was achieved by cross-referencing expert testimony with technical literature and regulatory communications to validate assertions about material properties, sterilization compatibility, and clinical use cases.

Analytical techniques included qualitative coding of expert interviews to identify recurring themes, scenario analysis to assess tariff and supply-chain impacts, and cross-regional comparison to elucidate regulatory and procurement differences. Where appropriate, risk matrices and decision frameworks were employed to prioritize strategic actions for manufacturers and health-system purchasers, focusing on feasibility, impact, and time-to-implement criteria.

While this methodology emphasizes qualitative rigor and triangulation, findings were continuously checked against clinical usability considerations and regulatory requirements to ensure recommendations are both actionable and aligned with stakeholder expectations. The methodology supports reproducibility by documenting interview parameters, source types, and analytic approaches used to derive the insights presented.

Conclusion on the Strategic Imperatives for Stakeholders Navigating the Transition to Non-PVC Intravenous Solutions

The transition toward non-PVC IV bags reflects broader healthcare trends that prioritize patient safety, environmental responsibility, and supply chain resilience. Material innovation, regulatory emphasis on extractables and leachables, and healthcare procurement frameworks that incorporate sustainability criteria collectively create a landscape in which technical performance must be matched by demonstrable safety and lifecycle credentials. Organizations that align product design, testing, and supply strategies with these imperatives will be better positioned to win institutional trust.

Strategic attention to supply chain architecture and tariff resilience will continue to influence procurement dynamics, prompting manufacturers to pursue regional production, secure diversified suppliers, and provide transparent sourcing documentation. At the same time, product differentiation through clinical evidence, compatibility with existing infusion ecosystems, and support services will determine the pace of adoption across hospitals, clinics, ambulatory centers, and home-care environments.

Ultimately, the shift away from PVC is a multi-dimensional challenge that requires coordinated action across R&D, regulatory affairs, manufacturing, and commercial teams. Companies that proactively address material validation, regulatory expectations, and customer operational needs can convert these challenges into competitive advantages, supporting safer patient outcomes and more sustainable healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Non-PVC IV bags Market, by Product Type

  • 8.1. Multi Chamber
    • 8.1.1. Three Chamber
    • 8.1.2. Two Chamber
  • 8.2. Single Chamber

9. Non-PVC IV bags Market, by Material

  • 9.1. Ethylene Vinyl Acetate
  • 9.2. Polyethylene
  • 9.3. Polypropylene

10. Non-PVC IV bags Market, by Capacity

  • 10.1. 500 To 1000 Ml
  • 10.2. Greater Than 1000 Ml
  • 10.3. Less Than 500 Ml

11. Non-PVC IV bags Market, by Application

  • 11.1. Blood Collection
  • 11.2. Dialysis
  • 11.3. Infusion Therapy
  • 11.4. Nutrition Therapy

12. Non-PVC IV bags Market, by End User

  • 12.1. Ambulatory Centers
  • 12.2. Clinics
  • 12.3. Home Care
  • 12.4. Hospitals

13. Non-PVC IV bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Non-PVC IV bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Non-PVC IV bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Non-PVC IV bags Market

17. China Non-PVC IV bags Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. BRAUN MELSUNGEN AG
  • 18.6. BAXTER INTERNATIONAL INC.
  • 18.7. China Resources Double-Crane Pharmaceutical Co., Ltd.
  • 18.8. CHONGQING KANGJIE MEDICAL INSTRUMENTS CO., LTD.
  • 18.9. Cisen Pharmaceutical Co., Ltd.
  • 18.10. FRESENIUS KABI AG
  • 18.11. Huaren Pharmaceutical Co., Ltd.
  • 18.12. ICU MEDICAL, INC.
  • 18.13. Jiangxi Sanxin Medtec Co., Ltd.
  • 18.14. JW Life Science Corporation
  • 18.15. NIPRO CORPORATION
  • 18.16. Otsuka Pharmaceutical Co., Ltd.
  • 18.17. Pharmaceutical Solutions Industry Limited
  • 18.18. POLY MEDICURE LIMITED
  • 18.19. PolyCine GmbH
  • 18.20. PROTEK MEDICAL (SHANGHAI) CO., LTD.
  • 18.21. RENOLIT SE
  • 18.22. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 18.23. Shanghai XinGen Eco-Technologies Co., Ltd.
  • 18.24. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 18.25. Sippex
  • 18.26. SSY Group Limited
  • 18.27. Technoflex SAS
  • 18.28. TERUMO CORPORATION
  • 18.29. Wellpharma Medical Solutions L.L.C.
  • 18.30. WUJIANG DONGLI MEDICAL PRODUCTS CO., LTD.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NON-PVC IV BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NON-PVC IV BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY THREE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY TWO CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY SINGLE CHAMBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY ETHYLENE VINYL ACETATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY 500 TO 1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GREATER THAN 1000 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY LESS THAN 500 ML, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY BLOOD COLLECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY DIALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY INFUSION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. GCC NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GCC NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. GCC NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. GCC NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 132. GCC NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. G7 NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. G7 NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 152. G7 NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. NATO NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. NATO NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 160. NATO NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL NON-PVC IV BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA NON-PVC IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA NON-PVC IV BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA NON-PVC IV BAGS MARKET SIZE, BY MULTI CHAMBER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA NON-PVC IV BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA NON-PVC IV BAGS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA NON-PVC IV BAGS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA NON-PVC IV BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)